Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859 · see citing works

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works

The molecular neurobiology of depression

Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · see citing works

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · see citing works

Major depressive disorder

Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166 · see citing works

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression

David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267 · see citing works

Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · see citing works

IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress

Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · see citing works

Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment

Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787 · see citing works

Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling

Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., & Krönke, M. (1994) · Cell · doi:10.1016/0092-8674(94)90275-5 · Cited by 714 · see citing works

CD95 Signaling via Ceramide-rich Membrane Rafts

Grassmé, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., & Gulbins, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101207200 · Cited by 637 · see citing works

Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Kim, M. Y., Linardic, C. M., Obeid, L. M., & Hannun, Y. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52461-3 · Cited by 628 · see citing works

Epidemiology of comorbid coronary artery disease and depression

Rudisch, B. E., & Nemeroff, C. B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00587-0 · Cited by 551 · see citing works

Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts

Grassmé, H., Jendrossek, V., Riehle, A., von Kürthy, G., Berger, J., Schwarz, H., Weller, M., Kolesnick, R., & Gulbins, E. (2003) · Nature Medicine · doi:10.1038/nm823 · Cited by 536 · see citing works

Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease

Horinouchi, K., Erlich, S. S., Perl, D. P., Ferlinz, K., Bisgaier, C. L., Sandhoff, K., Desnick, R. J., Stewart, C. L., & Schuchman, E. H. (1995) · Nature Genetics · doi:10.1038/ng0795-288 · Cited by 471 · see citing works

PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation

Peltier, J., O'Neill, A., & Schaffer, D. V. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20506 · Cited by 443 · see citing works

Activation of the Sphingomyelin Signaling Pathway in Intact EL4 Cells and in a Cell-Free System By IL-1β

Mathias, S., Younes, A., Kan, C.-C., Orlow, I., Joseph, C. K., & Kolesnick, R. (1993) · Science · doi:10.1126/science.8424175 · Cited by 433 · see citing works

Raft ceramide in molecular medicine

Gulbins, E., & Kolesnick, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207146 · Cited by 425 · see citing works

Fas- or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153

Brenner, B., Koppenhoefer, U., Weinstock, C., Linderkamp, O., Lang, F. J. W., & Gulbins, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22173 · Cited by 297 · see citing works

Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation Model

Kornhuber, J., Tripal, P., Reichel, M., Terfloth, L., Bleich, S., Wiltfang, J., & Gulbins, E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070524a · Cited by 225 · see citing works

Depression, inflammation, and pain in patients with rheumatoid arthritis.

Kojima, M., Kojima, T., Suzuki, S., Oguchi, T., Oba, M., Tsuchiya, H., Sugiura, F., Kanayama, Y., Furukawa, T. A., Tokudome, S., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24647 · Cited by 217 · see citing works

Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine

Kölzer, M., Werth, N., & Sandhoff, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00033-x · Cited by 200 · see citing works

Mutations in the Caenorhabditis elegans Serotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine

Ranganathan, R., Sawin, E. R., Trent, C., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05871.2001 · Cited by 188 · see citing works

Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids

Lepple‐Wienhues, A., Belka, C., Laun, T., Jekle, A., Walter, B., Wieland, U., Welz, M., Heil, L., Kun, J., Busch, G. L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13795 · Cited by 180 · see citing works

Serotonin (5HT), Fluoxetine, Imipramine and Dopamine Target Distinct 5HT Receptor Signaling to Modulate Caenorhabditis elegans Egg-Laying Behavior

Dempsey, C. M., Mackenzie, S. M., Gargus, A., Blanco, G., & Sze, J. Y. (2005) · Genetics · doi:10.1534/genetics.104.032540 · Cited by 157 · see citing works

High activity of acid sphingomyelinase in major depression

Kornhuber, J., Medlin, A., Bleich, S., Jendrossek, V., Henkel, A. W., Wiltfang, J., & Gulbins, E. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0374-5 · Cited by 143 · see citing works

COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.

Müller, N. (2010) · PubMed · Cited by 122 · see citing works

Acid Sphingomyelinase Amplifies Redox Signaling in Pseudomonas aeruginosa -Induced Macrophage Apoptosis

Zhang, Y., Li, X., Carpinteiro, A., & Gulbins, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4247 · Cited by 109 · see citing works

Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression

Brink, C. B., Harvey, B. H., & Brand, L. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906775245327 · Cited by 67 · see citing works

Syntaxin 4 Is Required for Acid Sphingomyelinase Activity and Apoptotic Function

Perrotta, C., Bizzozero, L., Cazzato, D., Morlacchi, S., Assi, E., Simbari, F., Zhang, Y., Gulbins, E., Bassi, M. T., Rosa, P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139287 · Cited by 66 · see citing works

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants

Baumann, P., Ulrich, S., Eckermann, G., Gerlach, M., Kuss, H., Laux, G., Müller-Oerlinghausen, B., Rao, M. L., Riederer, P. F., Zernig, G., et al. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/pbaumann · Cited by 64 · see citing works

Psychiatric Disorders in Patients with Immune-Mediated Inflammatory Diseases: Prevalence, Association with Disease Activity, and Overall Patient Well-being

Walker, J., Graff, L., Dutz, J., & Bernstein, C. (2011) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.110900 · Cited by 53 · see citing works

Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells

Stefanis, D. D., Reffo, P., Bonelli, G., et al. (2002) · Biological Chemistry · doi:10.1515/bc.2002.106 · Cited by 32 · see citing works

Niemann–Pick Disease versus acid sphingomyelinase deficiency

Lozano, J., Morales, A., Cremesti, A. E., et al. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400775 · Cited by 27 · see citing works

Sphingolipids and Atherosclerosis

Tabas, I. A. (2004) · Circulation · doi:10.1161/01.cir.0000150861.98087.56 · Cited by 22 · see citing works

Increased drinking after intra-striatal injection of the dopamine D2/D3 receptor agonist quinpirole in the rat

Amato, D., Müller, C. P., & Badiani, A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2735-8 · Cited by 12 · see citing works

In vivo influence of ceramide accumulation induced by treatment with a glucosylceramide synthase inhibitor on ischemic neuronal cell death

Hisaki, H., Shimasaki, H., Ueta, N., et al. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.042 · Cited by 12 · see citing works

Repairing mitochondrial dysfunction in disease

Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337 · see citing works

Brain membrane lipids in major depression and anxiety disorders

Müller, C. P., Reichel, M., Mühle, C., Rhein, C., Gulbins, E., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.014 · Cited by 308 · see citing works

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Hoertel, N., Sánchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.-S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01021-4 · Cited by 269 · see citing works

Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells

Carpinteiro, A., Edwards, M. J., Hoffmann, M., Kochs, G., Gripp, B., Weigang, S., Adams, C., Carpinteiro, E., Gulbins, A., Keitsch, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100142 · Cited by 184 · see citing works

The role of serotonin in adult hippocampal neurogenesis

Alenina, N., & Klempin, F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.038 · Cited by 195 · see citing works

Lipids in Psychiatric Disorders and Preventive Medicine

Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175 · see citing works

LDL cholesterol relates to depression, its severity, and the prospective course

Wagner, C. J., Musenbichler, C., Böhm, L., Färber, K., Fischer, A.-I., von Nippold, F., Winkelmann, M., Richter-Schmidinger, T., Mühle, C., Kornhuber, J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.010 · Cited by 106 · see citing works

Lipidomics in Major Depressive Disorder

Walther, A., Cannistraci, C. V., Simons, K., Durán, C., Gerl, M. J., Wehrli, S., & Kirschbaum, C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00459 · Cited by 77 · see citing works

Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase

Park, M. H., Jin, H. K., & Bae, J.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0399-8 · Cited by 59 · see citing works

Antidepressants and the adolescent brain

Cousins, L., & Goodyer, I. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573542 · Cited by 61 · see citing works

Erasing m6A-dependent transcription signature of stress-sensitive genes triggers antidepressant actions

Wu, P.-F., Han, Q.-Q., Chen, F.-F., Shen, T.-T., Li, Y.-H., Cao, Y., Chen, J.-G., & Wang, F. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100390 · Cited by 32 · see citing works

Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition

Har'kavenko, V., Storozhenko, G., Krasnikova, O., et al. (2012) · Fìzìologìčnij žurnal · doi:10.15407/fz58.01.056 · Cited by 1 · see citing works

Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.

Sn, R., Somova, O. G., Zubova, E. S., et al. (1999) · PubMed · Cited by 8 · see citing works

Lysenin: A sphingomyelin specific pore-forming toxin

Shogomori, H., & Kobayashi, T. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.001 · Cited by 91 · see citing works

Elevated levels of sphingolipids in type II (a+b) hyperlipoproteinemia

Auran, T. B., Zavoral, J. H., & Krivit, W. A. (1974) · Thrombosis Research · doi:10.1016/0049-3848(74)90066-8 · Cited by 3 · see citing works

Dietary sphingomyelin and other sphingolipids in health and disease

Schmelz, E. M. (2000) · Nutrition Bulletin · doi:10.1046/j.1467-3010.2000.00031.x · Cited by 34 · see citing works